The decade-long Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study wrapped up this month. According to top-line results announced March 8 by Eli Lilly, more than four years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback